Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Sulfonylurea
Related studies linked through entity extraction aliases.
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
- Status
- COMPLETED
- Phase
- N/A
Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas
- Status
- WITHDRAWN
- Phase
- N/A
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
- Status
- UNKNOWN
- Phase
- PHASE4
Study of Sulphonylurea Synergy With DPP4 Inhibitors
- Status
- COMPLETED
- Phase
- NA
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
- Status
- COMPLETED
- Phase
- PHASE4
Replication of the TECOS Diabetes Trial in Healthcare Claims
- Status
- COMPLETED
- Phase
- N/A
Replication of the CARMELINA Diabetes Trial in Healthcare Claims
- Status
- COMPLETED
- Phase
- N/A
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims
- Status
- COMPLETED
- Phase
- N/A
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
- Status
- COMPLETED
- Phase
- PHASE4
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
- Status
- COMPLETED
- Phase
- PHASE4
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
- Status
- UNKNOWN
- Phase
- PHASE4
Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3